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Epidermal Notch1 recruits RORgþ group 3 innate
lymphoid cells to orchestrate normal skin repair
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Notch has a well-deﬁned role in controlling cell fate decisions in the embryo and the adult
epidermis and immune systems, yet emerging evidence suggests Notch also directs non-cell-
autonomous signalling in adult tissues. Here, we show that Notch1 works as a damage
response signal. Epidermal Notch induces recruitment of immune cell subsets including
RORgþ ILC3s into wounded dermis; RORgþ ILC3s are potent sources of IL17F in wounds and
control immunological and epidermal cell responses. Mice deﬁcient for RORgþ ILC3s heal
wounds poorly resulting from delayed epidermal proliferation and macrophage recruitment in
a CCL3-dependent process. Notch1 upregulates TNFa and the ILC3 recruitment chemokines
CCL20 and CXCL13. TNFa, as a Notch1 effector, directs ILC3 localization and rates of wound
healing. Altogether these ﬁndings suggest that Notch is a key stress/injury signal in skin
epithelium driving innate immune cell recruitment and normal skin tissue repair.
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W
ound healing in epithelial tissues involves three
phases; inﬂammation, proliferation and remodel-
ling1,2. Following injury, neutrophils and phagocytic
cells inﬁltrate clearing microbial contaminants. The subsequent
proliferative phase is characterized by epidermal proliferation,
extracellular matrix deposition, granulation, vascularization and
wound contraction. Following wound closure, excess cells and
debris are removed in the remodelling phase and the extracellular
matrix is reorganized to restore tissue strength. At the wound site,
adaptive and innate immune cells regulate the skin wound
healing process through production of cytokines, antimicrobial
peptides and growth factors. Wound healing is not obligate on a
functional immune system; most immune-deﬁcient models heal
wounds3,4. However, research shows macrophages have key roles
in wound closure5. Further in mice, injury activates epidermal-
resident gd T cells called dendritic epidermal T cells (DETCs) to
produce growth factors and inﬂammatory cytokines that control
the epithelial injury response6. Whether the immune system helps
or hinders effective repair remains controversial. Athymic nude
mice undergo complete, scarless repair3,7, while conversely,
macrophage persistence in wound sites leads to ﬁbrosis and
scar formation; thus proper timing of immune cell entry and exit
is critical for normal repair1,8.
The Notch pathway is a key, cell-autonomous signalling
pathway that directs cell fate and has pleiotropic functions in the
skin9–11. Notch signalling initiates when a Notch ligand binds to
one of the four receptors present on mammalian cells, which
causes receptor cleavage and enables the intracellular domain to
undergo nuclear translocation, and effect changes in gene
transcription12. Expression of all four Notch receptors in the
epidermis has been reported13. However, genetic studies suggest
Notch1 and Notch2 are the primary receptors needed to regulate
the cell differentiation required to maintain hair and skin
epithelia14. A previous study using topically-applied pan-Notch
activators and inhibitors suggested that Notch might be involved
in wound healing15, and our previous work showed that forced,
ectopic epidermal Notch1 activity resulted in extensive epidermal
proliferation and severe inﬂammation, two phenotypic hallmarks
of skin wound healing9,16,17.
Innate lymphoid cells (ILCs) are rare populations of lympho-
cytes that have key roles in secondary lymphoid tissue formation,
homoeostasis and rapid production of cytokines in response to
pathogen infection. ILCs are classiﬁed by cytokine production
and expression of transcription factors into three groups, termed
group 1, 2 or 3, and are found largely within the stroma of
mucosal tissues18. Group 1 or ILC1s in mucosal epithelium
produce interferon-g-mediated responses against pathogens and
are thought to contribute to intestinal pathologies when
dysregulated, while Group 2 (ILC2s) are linked to allergenic
responses and, in skin, to atopic dermatitis through the
production of type 2 cytokines, IL5 and IL13 (refs 19–23).
Group 3 or ILC3s are characterized by the expression of RORg
transcription factor and have key roles in the maintenance and
repair of epithelial tissues. Further, ILC3s contribute to intestinal
epithelial repair through IL22 upregulation24, and through
ILC3-mediated release of granulocyte macrophage colony
stimulating factor (GM-CSF) controlling macrophage and
dendritic cell responses to gut commensal microﬂora25,26. In
skin, recent studies have linked ILC3s to the pathogenesis of
psoriasis through IL23a stimulated IL17 and IL22 production.
However, despite the similarity of skin and intestine as barrier
organs, the contribution of ILCs to the physiology of normal skin
tissue repair remained unstudied.
In this study, we show that damage activates epidermal Notch
signalling. Notch in turn, controls dermal entry
of inﬂammatory cell subsets, including NKp46low/–CD4þ
ILC3s to wound sites. In uninjured mouse and human skin,
dermis-resident ILC3s are exceptionally rare, but Notch-
controlled epidermal signals recruit ILC3s in a TNFa-dependent
process. Furthermore, using RORgþ -deﬁcient mice, we present
evidence that RORgþ ILC3s, in wounds, produce IL17F and
CCL3 (also known as MIP1a) and have key roles the normal
healing response; ILC3s control epidermal proliferation and
macrophage entry into the dermis.
Results
Skin injury activates Notch1 signalling. To determine the roles
of Notch in wound healing, 6-week-old mice were given two,
full-thickness punch wounds, and back skin tissues were analysed
for Notch1 at 1, 3/4 and 7 days post wounding (dpw). Wounding
caused an immediate increase (B7 ) in Notch1 activity 1 dpw
with peak activity detected 4 dpw (B16 ) (Fig. 1a). Stained
sectioned tissues revealed Notch1 was primarily active in supra-
basal epidermal keratinocytes 1 and 4 dpw (Fig. 1b and
Supplementary Fig. 1). A signiﬁcant increase in Jagged1 and
Jagged2 messenger RNA (mRNA) expression was detected by
quantitative real time PCR (QPCR) within 8 h of injury (Fig. 1c).
Published studies show skin dendritic cells in the mouse ear can
upregulate the Notch ligands Jagged1 and Jagged2 in response to
damage27, however we detected Jagged1 protein in basal and
suprabasal epidermal layers 2 and 5 dpw. This suggests that
Notch ligands are available locally in the epidermis to activate
Notch during wound healing (Fig. 1d). We conclude that the
Notch pathway is active in the inﬂammatory and proliferation
phases of wound healing.
Epidermal Notch1 drives dermal immune responses after injury.
Our previous work showed that epidermal Notch activity, via
Jagged1, stimulates epidermal production of pro-inﬂammatory
TNFa and persistent Notch activity leads to CD3þCD4þ
T cell recruitment9,17. Thus we hypothesized that Notch
signalling leads to inﬂammatory cell recruitment following
injury (Fig. 2a). We quantiﬁed populations of dermal immune
cells in unwounded skin (UW) and punch-wounded skin during
the inﬂammatory, proliferation and early remodelling phases
at 2, 5 and 8 dpw, respectively. Wounding induced the expected
early inﬂux of CD11bþGr-1þ polymorphonuclear neutrophils
and CD11bþF4/80þ monocytes/macrophages (Supplementary
Fig. 2a,b). The percentage of anti-inﬂammatory M2 macrophages
was determined by CD206 marker expression; in alignment with
previously published studies, the macrophage population was
heterogeneous throughout skin repair, with 78–87% of
macrophages expressing the M2 marker at all wound stages
investigated (Supplementary Fig. 2d)28. CD206 marker
expression was quantiﬁed on spleen cells as an experimental
control and, in agreement with published studies, we detected
B20% of splenocytes expressing CD206 (Supplementary Fig. 2d).
NK1.1þ (NK and/or NKT) cell numbers peaked at 8 dpw
(Supplementary Fig. 2c) consistent with a role in tissue
remodelling. Next, we examined the innate lymphoid cell
populations, as these cells were known to have roles in
intestinal tissue repair and skin pathology. Increased numbers
of ILC2s were detected by 8 dpw; while an increase in ILC1s was
detected at 5 and 8 dpw during the late proliferation and
remodelling phases of wound healing when IFNg levels are high
(Supplementary Fig. 2e,f)19. RORgþCD127þLin– ILC3s were
detected, yet these cells comprised a very small proportion of total
back skin cells, o1% of total dermal cells, at all time points
(Fig. 2b,c). In summary, our data show that injury controls
localized and temporal recruitment of leukocytes including ILC
subsets.
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We theorized that the small numbers of ILC3s detected by ﬂow
cytometry were likely due to the inclusion of dermal cells from
both wounded and non-wounded skin. To test if wounding
caused localized recruitment of ILC3s to wound sites, we
examined the distribution of RORgþ ILC3s in sectioned wound
tissues (Fig. 2d). At all time points post wounding ILC3s were
detected in the dermis. At 2 dpw, most ILC3s were found in the
reticular dermis, however by 5 and 8 dpw ILC3s were detected in
both the reticular and papillary dermis, suggesting active
recruitment of cells from the reticular blood vascular network
into the dermis (Fig. 2d). Similarly in human skin, we detected
inﬁltration of dermal RORgþCD127þCD3– ILCs following
wounding using a punch biopsy (Supplementary Fig. 3a). In
mice tissues, the distribution of ILC3s was quantiﬁed relative to
the epidermal wound edge as deﬁned by the distinctive
phenotypic appearance of this tissue (Fig. 2e,f). Most RORgþ
ILC3s were localized nearest to the wound site within 1mm of the
wound edge (zone 1) and maximal numbers were detected at 5
dpw during the proliferative phase (Fig. 2d). As controls, sections
from wounded RORg / mice were stained with RORg
antibodies; no staining was detected conﬁrming speciﬁc
immunoreactivity of RORg antibodies in tissue sections
(Supplementary Fig. 4a). ILC3 subsets differentially express
NKp46 and CD4, so we analysed the surface marker expression
in RORgeGFP/þ skin (Supplementary Fig. 4b)29. The majority of
RORg-eGFPþ cells were CD4þ , and expressed very low levels of
NKp46 with heterogeneous expression of CD117, thus
CD4þNKp46low/– ILC3s. Further, these ILC3s expressed the
chemokine receptors, CCR6, CXCR4 and CXCR5, important for
ILC3 chemotaxis (Supplementary Fig. 4b).
Having established the timed cascade of immune cell
inﬁltration in skin wounds, we next investigated the link between
injury-activated epidermal Notch and the dermal accumulation of
ILC3s and other immune cell subsets. Previously we published a
K14NICDER transgenic mouse model where Notch1 activity can
be tightly controlled in the epidermis by drug application. A full
characterization of this mouse model has been previously
published9,17. In brief, the K14NICDER transgene contains a
truncated, Notch1 intracellular domain (NICD) that can be
temporally and spatially activated by 4-hydroxy-tamoxifen
(4OHT) in the basal, keratin 14-expressing epidermis. Here,
Notch was activated by 4OHT in transgenic mice for 3 days.
Control mice were likewise 4OHT treated and sectioned tissues
were antibody stained to visualize Gr-1þ neutrophils, F4/80þ
macrophages and RORgþ ILC3s (Fig. 3a–c). Only rare neutrophils
were detected in both 4OHT-treated transgenics and controls
(Fig. 3a), but a substantial increase in the number of macrophages
and ILC3s were detected in transgenic dermis compared to control
tissue (Fig. 3b,c), suggesting that epidermal Notch activation in the
absence of tissue damage is sufﬁcient to drive recruitment of subsets
of wound-induced dermal immune cells.
Next, we inhibited Notch1 receptor activation using NRR1
blocking antibodies, which block ligand binding to Notch1
receptor but not the other Notch receptors, thus speciﬁcally
inhibiting Notch1 signalling30. As controls, mice were treated
with NRR2 blocking antibodies, which have equivalent efﬁcacy
against Notch2 receptors, isotype IgG antibodies or phosphate
buffered saline (PBS). Mice were injected intraperitoneally (i.p.)
for 7 days before wounding, and we conﬁrmed that antibody
treatment caused expected systemic effects; NRR1-treated mice
were blocked in thymocyte development and NRR2-treated mice
were blocked in marginal zone B cell maturation, Notch1 and
Notch2 dependent processes, respectively (Supplementary
Fig. 5a)30. Following wounding, closure rates were measured
and tissues collected 2 or 5 dpw. Wounds treated with the Notch1
blocking antibody, NRR1, were signiﬁcantly more open (77%) 2
dpw compared to mice injected isotype IgG control (66%), but by
5 dpw wound size in NRR1-treated mice did not differ from
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Figure 1 | Notch1 is activated in wounded skin; the Notch ligands Jagged1 and Jagged2 are upregulated in response to injury. Back skin tissues from
punch-wounded wildtype mice were collected 4, 8, 16 h and 1, 2, 4, 5 and 7 dpw. (a) Graph summary of cleaved, activated Notch1 protein levels quantiﬁed
by antibody detection in a western immunoblotting assay (Supplementary Fig. 9a). Notch1 levels were standardized to b-actin levels as a loading control
and normalized to Notch1 levels (designated as 1) in uninjured littermate mice. Unwounded back skin was taken from a punch-wounded mouse at a distal
site (minimum 2 cm) from wound site. n¼ 3 biological replicates each time point post wounding. Normally-distributed data was compared by Student’s t-
test between wounded and unwounded samples. (b) Section stained with antibodies speciﬁc for activated Notch1 on tissue collected 4 dpw. Note activated
Notch1 is detectable in all epidermal layers. (c) mRNA levels of Jagged1 or Jagged2 quantiﬁed by qPCR in unwounded (0 h) and wounded back skin 4, 8,
16 h (h) post wounding. mRNA levels were normalized to UW. (d) Sections were stained for anti-Jagged 1 (green) on unwounded, 2 and 5 dpw. White
asterisks (b,d) mark wound site; white dash line denotes epidermal/dermal boundary (b,d). Graph bars represent experimental mean of 3 or more
biological replicates and error bars represent standard error of the mean (s.e.m.); Results statistically signiﬁcant marked with ** or ***; P-values included on
graphs. Scale bars equal 50 microns. All experiments were repeated Z2 times.
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controls (Fig. 4a,b). NRR1-treated wounds displayed a distinct
phenotype; wounds showed increased erythema, with domed
margins (signs of abnormal wound granulation), compared to
controls (Fig. 4a). Following treatment with NRR1, detectable
nuclear activated Notch1 was reduced in the epidermal layers as
detected by antibody staining, and total cleaved, active Notch1
protein was reduced in whole skin preparations quantiﬁed by
western immunoblotting (Supplementary Fig. 5c,d). No
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Figure 2 | ILC3s populate dermis in response to skin wounding. (a) Schematic of experimental hypothesis; Notch activation following injury in
keratinocytes (green) induces innate immune cell recruitment (represented by purple, blue and orange cells) into the underlying dermis. (b,c) Dorsal back
skin from UW or punch-wounded (4mm biopsy) wildtype animals were collected 2, 5 or 8 dpw. Whole back skin tissues were digested to single cell
suspensions and co-stained with a lineage antibody panel (Lin) that react with cells from the major hematopoietic cell lineages and antibodies to CD45,
CD127 and RORgt. (b) Cells were ﬁrst gated for CD45þ and Lin–, then analysed for co-expression of CD127 and RORgt. (c) The percentage of
CD45þ LinCD127þRORgtþ cells (ILC3s) in the total cell population was calculated for UW or wounds 2, 5 and 8 dpw. Per cent (%) total skin cells;
averages of three biological replicates. (d) Back skin sections from unwounded mice or from punch-wounded (4mm) tissues collected 2, 5 or 8 dpw
stained with an antibody to RORg (green). Embedded insets are higher magniﬁcation images of the boxed region in the accompanying panel. RORgþ cells
are marked by white arrows and wound site marked by white asterisk. (e,f) Quantiﬁcation of RORgþ cells adjacent to wounds analysed by two-way
ANOVA with statistical signiﬁcance (marked with a single black asterisk, f) between zones calculated by Bonferroni’s multiple comparison test. Zone
1¼ area from edge of wound to 1mm distal from wound edge, zone 2¼ region 1–1.5mm distal from wound edge and zone 3¼ region 1.5–2mm distal from
wound edge. (f) Red line denotes average number of RORgþ cells in unwounded dermis (1.47±0.87 per mm2). Graph bars are average cell numbers from
3 sections from 3 biological replicates; scale bars equal 100 microns.
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difference in basal and suprabasal marker expression was detected
in NRR1 and control-treated skin suggesting NRR1 treatment
did not block differentiation of epidermal keratinocytes
(Supplementary Fig. 5e).
The impact of reduced Notch1 activation on wound-recruited
dermal immune cells was assessed in sectioned tissues and by
ﬂow cytometry in NRR1-treated mice. At 2 dpw, most dermal
immune cell populations were similar in NRR1 and IgG
control-treated wounds (Fig. 4c; Supplementary Fig. 5f) with
the exception of ILC3s; fewer dermal ILC3s were detected
adjacent to wounds at 2 dpw (Supplementary Fig. 4f). At 5 dpw,
reduced Notch1 levels led to fewer dermal CD11bþ leukocytes,
NK1.1þ cells, ILC1s and ILC3s (Fig. 4c,d). We conﬁrmed that
Notch1, but not Notch2 activity was directly linked to RORgþ
ILC3 recruitment; ILC3 recruitment was inhibited in wounded
mice treated with NRR1, but not NRR2, blocking antibodies
(Fig. 4e).
Taken together these results demonstrate that Notch, as a
damage response factor, directs recruitment of dermal immune
cells. Further, we found a novel link between epidermal Notch
activity and ILC3 recruitment to wound sites. Given the key roles
of ILC3s in regulating mucosal tissue repair, we next investigated
the Notch-regulated mechanism leading to ILC3 recruitment and
their functions in skin repair.
Epidermal Notch1 drives TNFa-mediated recruitment of ILC3s.
To investigate the mechanism by which Notch1 leads to
ILC3 recruitment, dermal and epidermal gene expression proﬁles
of uninjured, K14NICDER transgenic mouse back skin
(NIH GEO:GSE23782 (ref. 9)) were examined. IPA software was
used to identify secreted factors upregulated in 4OHT-treated
K14NICDER skin (6 or greater) that could facilitate immune
cell inﬁltration into the dermis and the subsequent activation
(Fig. 5a,b). Analysis identiﬁed several key candidates that
could regulate innate immune cell recruitment and activation
(NIH GEO: GSE29777 (ref. 31)). Of these, Notch-regulated factors
CCL20 (14.1 ), CXCL12 (8.0 ) and CXCL13 (6.5 ) were of
particular interest as these factors directly regulate ILC3s; and we
showed that the cognate receptors CCR6, CXCR4 and CXCR5 for
the ligands CCL20, CXCL12 and CXCL13, respectively, are
expressed on wound-recruited ILC3s (Supplementary Fig. 4b and
Fig. 5a,b)32. Further, TNFa (17.1 ) was also of interest, as it can
direct CCL20 expression in the epidermis33 and CCL20 is a key
recruitment factor for RORgþ ILC3s in lymphoid tissues34.
The ligand/receptor pairings of CCL20/CCR6, CXCL12/
CXCR4 and CXCL13/CXCR5 have vital chemotactic functions
in many immune cells including ILCs, dendritic cells (DCs) and T
and B cells. Innate immune cell recruitment in mucosal
epithelium is CCL20/CCR6 dependent35. Skin wounding caused
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Figure 3 | Epidermal Notch activation drives dermal recruitment of ILC3s and F4/80þ macrophages. Back skin sections of K14NICDER transgenic and
littermate control mice treated with 4OHT for 3 days and stained with antibodies to Gr-1 (a, green), F4/80 (b, green) or RORg (c, green). White arrows
mark either Gr-1þ (a) or RORgþ (c) cells. Note rare Gr-1þ neutrophils (a, white arrows) were detected in transgenic and control mice, however F4/80þ
(b) and RORgþ (c, white arrows) cells are abundant in stained K14NICDER back skin sections; scale bars equal 100microns; experiments were repeated
Z3 times.
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robust, early activation of Notch1 (Fig. 1b), thus we measured
CCL20, CXCL12 and CXCL13 mRNA levels at early time points
(4, 8, 16, 24, 40, 48 and 120 h) after injury by quantitative PCR
(qPCR) (Fig. 5c). CCL20 and CXCL13 levels were elevated
immediately following wounding and returned to near
background levels by 40 h post injury and remained low
(Fig. 5c). No increase in CXCL12 mRNA levels was detected
from 0 to 24 h post wounding, with a moderate increase in
CXCL12 levels after 48 h. In human wounds, CXCL13 and CCL20
were also differentially regulated with highest expression observed
early during the inﬂammatory phase (Supplementary Fig. 3b).
The early activation of CCL20 and CXCL13 in wounded tissues,
and in Notch-active transgenic mice, suggests that Notch has a
role in their activity. Mice with reduced Notch activity (NRR1
treated) had lower levels of CXCL13, but not CCL20 compared to
controls (Fig. 5d). These data link Notch activity to CXCL13
activation, yet we cannot rule out a role for Notch1 in CCL20
activation as in our model Notch activity is reduced, not fully
blocked. However, CXCL13 and CCL20 were transcriptionally
downregulated within 24-h of injury, while Notch1 activity
remained high (Fig. 1a) suggesting other transcriptional
regulators are also likely important.
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control-treated samples was used to determine signiﬁcance marked with **; P-values included on graphs. (e) Sections of wounds 5 dpw from NRR1 or
NRR2-treated mice stained with an antibody to RORg (green). RORgþ cells marked by white arrows and wound sites marked with white asterisks.
Wounding recruits RORgþ cells into the dermis; pre-treatment with NRR1, but not NRR2 receptor blocking antibodies inhibits RORgþ cell inﬁltrate after
wounding; scale bars equal 100 microns.
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To test whether CCL20 and CXCL13 are essential chemokines
in ILC3 recruitment into skin wounds, we examined ILC3
recruitment in mutant mice deleted for single chemotactic
pathways. CCR6 / and CXCL13 / mice and their respective
littermate controls were punch wounded; wound closure rates
were monitored and tissue sections were analysed by immuno-
detection for RORgþ ILC3 recruitment at 5 dpw. There was no
detectable difference in wound closure rates between the mutant
and control mice. The number of dermal ILC3s in antibody-
stained CXCL13 / mutant tissue sections was not signiﬁcantly
different from controls (Supplementary Fig. 6a,b), whereas, a
small increase in ILC3 numbers was detected in CCR6 /
mutants compared to controls (Supplementary Fig. 6c,d). We
identiﬁed injury-induced upregulation of a third chemokine in
human wounds, CXCL16, that is known to regulate the
chemotaxis of both mouse ILC3s and human innate immune
cells (Supplementary Fig. 3b)29,36. Taken together these results
suggest multiple, redundant pathways are important in ILC3
chemotaxis.
Lastly, we found levels of TNFa corresponded to levels of
Notch activity in skin with increased (K14NICDER) and
decreased Notch activity following injury (wounded NRR1-
treated mice) (Fig. 5a,d)9. Thus, we determined if TNFa
downstream of epidermal Notch activity mediates ILC3
localization. In unwounded K14NICDER, TNFa activity was
blocked by injecting a TNFa blocking antibody, or PBS control,
daily for 7 days before 4OHT-activation of Notch. Antibody
staining on tissue sections revealed that anti-TNFa treatment
blocked Notch-mediated ILC3 localization into the skin (Fig. 5e).
To conﬁrm that TNFa regulates ILC3 dermal localization in
wounds, wounded animals were treated with recombinant TNFa,
TNFa blocking antibody or PBS daily. By 5 2dpw, a substantial
difference was observed between the three groups of mice: TNFa
accelerated wound closure and increased ILC3 numbers (1.8 ),
while the antagonist inhibited closure with reduced numbers of
ILC3s (0.4 ) (Fig. 5f,g and Supplementary Fig. 6e). Mechan-
istically, TNFa bioavailability may impact ILC3 recruitment
through regulating CCL20. Previous studies have shown that
CCL20 is produced from epidermal keratinocytes in response to
TNFa stimulation33, and we conﬁrmed that primary dermal cells
respond similarly (Supplementary Fig. 6f). However, it is almost
certain that multiple factors control CCL20 expression; TNFa
ca
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Figure 5 | Notch1 drives expression of TNFa that regulates ILC3 localization in wounds. (a,b) Factors upregulated by Notch in the (a) epidermis and (b)
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followed by 2 days of 4OHT-treatment labelled with antibodies to RORg (green) and DAPI counterstained. Embedded insets are higher magniﬁcation
images of the boxed region in the accompanying panel. (f) Punch wounds treated with PBS (vehicle), TNFa or TNFa blocking antibody (anti-TNFa)
photographed at 2 and 5 dpw. Note red, inﬂamed tissues evident adjacent to TNFa-treated wounds 2 dpw. Experiment repeated twice (total animal
numbers n¼4 control; n¼ 7 TNFa blocking antibody; n¼8 TNFa). (g) Quantiﬁcation of dermal RORgþ cells in wounded mice 2 dpw treated with vehicle,
TNFa or TNFa blocking antibody (n¼ 3 control; n¼ 5 TNFa; n¼ 5 TNFa antagonist; sample number¼ biological replicates; quantiﬁed area
o1,600micrometres distal to wound site). All panels: white arrows mark RORgþ cells. Error bars on graphs represent standard error of the mean (s.e.m.).
Scale bars equal 100microns. Results statistically signiﬁcant as determined by Student’s t-test (d,g) marked with ** or ***; P-values included on graphs.
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alone or in combination with IL-1b, CD40 ligand, IFNg,
and IL17 can all stimulate CCL20 production in epidermal
keratinocytes and dermal ﬁbroblasts (Supplementary Fig. 6f). In
summary, these results implicate a Notch/TNFa mechanism,
working in conjunction with chemokines, in ILC3 recruitment
into skin wounds.
The functional role of Notch-recruited ILC3s in skin wounds.
Innate lymphocytes and other cell types, including Th17 cells,
DETCs and dermal gd T cells, can be potent sources of IL17 and
IL22 cytokines that attenuate immune responses18,38–40. IL17A
production drives psoriatic inﬂammation in skin41 and
imiquimod-induced psoriatic-like lesions in mice express high
levels of IL17A and IL17F42. Further, the IL22 receptor signalling
pathway has a key role in skin wound healing43 and IL22 has a
key role in thymus regeneration20 and accelerates keratinocyte
closure in in vitro wound scratch assays24. ILC3s isolated from 5
dpw dermis were analysed for cytokine production by
intracellular ﬂow cytometry analysis (Fig. 6a). We analysed
IL17A, IL17F and IL22 cytokine production in unstimulated and
phorbol 12-myristate 13-acetate (PMA)/ionomycin-induced cells.
Although, we detected low levels of IL22-, IL17A- and IL17F-
producing cells among the population of unstimulated ILC3s,
following PMA/ionomycin, the majority of ILC3s predominantly
expressed IL17F, with a small fraction of cells double positive for
IL17A and IL17F. Similarly, human wounds populated with
dermal ILC3s have elevated levels of IL17F and IL17A
(Supplementary Fig. 3c). IL22 is difﬁcult to detect by ﬂow
cytometry, so in addition we examined mRNA levels by qRT-
PCR. We detected increased IL22 levels by 2 dpw consistent with
a potential role for ILC3s in producing IL22 needed for skin
repair (Fig. 6b). In summary, results suggest that ILC3s contribute
to normal physiological tissue repair in the skin through
production of IL17F and to a lesser extent IL17A and IL22.
To investigate the function of Notch-recruited ILC3s in skin
tissue repair, we examined the wound healing in RORg / and
littermate controls (Fig. 7a). We developed non-invasive 3D
imaging methods to quantify wound closure rates in these
animals. Brieﬂy, mice were photographed repeatedly using a 3D
camera and an accurate measurement of the wound perimeter
was calculated over time (Fig. 7b and Supplementary Fig. 7a–e).
Wounds were signiﬁcantly more open in RORg / mice given
4mm punch wounds compared to control littermates at 5 dpw
(Fig. 7a,b and Supplementary Fig. 6e). However, by 8 dpw,
wounds were of a similar openness in mutant and control mice
with re-epithelialization complete in both (Fig. 7b and
Supplementary Fig. 7e). Wound-healing defects were exacerbated
in RORg / mice with larger diameter (6mm) wounds. Larger
wounds take longer to close and wound were signiﬁcantly more
open at 8dpw in RORg / mice receiving large wounds
(Supplementary Fig. 7f). Delayed wound closure in RORg /
mice with small wounds (4mm) was linked to delayed
re-epithelialization of the keratinocyte layer; at 5 dpw, RORg /
mice had a marked reduction in Ki67þ epidermal cells compared
to controls (Supplementary Fig. 8a–c). We conﬁrmed that
phenotypes observed in the RORg / mice resulted from loss
of RORgþ ILC3s. We transplanted spleen cells from Rag2 /
mice (lacking ab and gd T cells, but containing RORgþ ILCs)
into RORg / mice 24 h before wounding. Cell transplantation
ameliorated wound pathology observed in control RORg /
mice and donor RORgþ ILCs could be detected adjacent to
wound sites (Supplementary Fig. 8d). Therefore, loss of ILCs in
RORg / mice directly causes wound pathology.
Crosstalk between ILC3s and macrophages has been shown to
regulate macrophage function in intestinal homoeostasis26, thus
we examined the inﬂammatory inﬁltrate in wounded RORg /
mice. We detected no change in neutrophil, intra-epidermal
macrophage and ILC2 numbers (Fig. 7c and Supplementary
Fig. 8e,f), however, a threefold reduction in F4/80þ dermal
macrophages was detected 2 dpw, as quantiﬁed in sectioned
tissues (Fig. 7c, bottom right panel), compared to wildtype
littermates. Rag2 / controls, which lack ab and gd T cells but
contain ILC3s, had normal macrophage numbers. Anti-Thy1.2
antibodies were used to deplete ILCs in the Rag2 /
background and 3.6-fold fewer ILC3s, and 2.7-fold decrease in
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ILC2s were detected by ﬂow cytometry in antibody-treated
animals 2 dpw (Supplementary Fig. 8g,h)44. Anti-Thy1.2-treated
Rag2 / mice had deﬁcient macrophage numbers at skin
wound sites conﬁrming that delayed macrophage recruitment
resulted from speciﬁc loss of dermal ILC3s, not T lymphocytes,
early in the wound-healing programme. In NRR1-treated mice
where ILC3 numbers are reduced, but not to zero, F4/80þ
macrophages could be detected, although few were found
adjacent to the site of injury compared to controls (Fig. 7c).
By 5 dpw, F4/80þ cells were plentiful within the dermis in
wildtype and RORg / wounds suggesting that loss of ILC3s
causes a delay, but not a block in macrophage/monocyte
inﬁltration (Fig. 7d). NRR1-treated animals had reduced numbers
of F4/80þ macrophages at 5 dpw. Quantiﬁcation by ﬂow
cytometry revealed similar trends; CD11bþ cell numbers were
at similar levels in both mutant and control wounds by 5 dpw,
while reduced in NRR1-treated animals (Fig. 7d, bottom right
panel). These results are consistent with previous reports
suggesting Notch1 has additional roles in regulating macro-
phage/monocyte responses to tissue damage45.
Decreased levels of CCL3, a key monocyte/macrophage
recruitment chemokine, were detected in RORg / skin at 2
dpw compared to wildtype and Rag2 / controls, but not in day
5 wounds (Fig. 7e). We analysed whether ILC3s produce CCL3;
CCL3 was detected in ILC3s isolated from 2 dpw, but not 5 dpw.
This suggests that CCL3 production by ILC3s is required for
early macrophage entry into wounded tissues in the healing
programme (Fig. 7f).
Discussion
Dysregulated Notch signalling has been linked to aberrant human
and mouse wound healing and our previous work linked aberrant
Notch activity with human keloid formation, however, the
mechanistic detail or the site of action was unknown9,15,46–48.
Here, using genetic and chemical tools to modulate Notch
activity17,30,49, we have shown that Notch1 activity in epidermal
keratinocytes has an essential temporal role in the wound-healing
process through action on dermal immune cell recruitment and
activation (Fig. 8). These ﬁndings are important, as it is clear that
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(b) or Student’s t-test (c,d) marked with ** or ***; P-values included on graphs.
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correct entry and exit of immune cells is essential for conven-
tional repair. Notch1 levels were highest in the inﬂammatory and
proliferation phases of the wound response, and during the later
remodelling phase when the epithelium has closed2, Notch1
activity returns to levels detected in UW. Jagged1 and Jagged2 are
similarly upregulated after injury and Jagged1 protein was
detected in the epidermis adjacent to wounds, suggesting
that Notch is activated through classical ligand–receptor
interactions in wound repair. Reducing epidermal Notch1
activity inhibits wound closure and innate immune cell
recruitment, and activating Notch1 in the epidermis without
tissue or barrier damage is sufﬁcient to drive expression of TNFa,
CXCL13 and CCL20 in the skin and induce recruitment of ILC3s
(Fig. 8).
Consistent with our ﬁndings using NRR1 blocking antibodies,
wound healing is also impaired in Notch1þ / mice; Notch1þ /
mice have reduced levels of TNFa and fewer F4/80þ macro-
phages near the site of injury45. The authors conclude these
defects arise from loss of Notch1 activity in macrophages and
inhibition of macrophage cytokine production45,50. However, our
results suggest that reduced Notch signalling in epithelial
keratinocytes in Notch1þ / mice likely contributes to wound-
healing defects. In our experiments, whole skin protein lysates
were used and as such some cleaved Notch1 protein may come
from macrophages, although the contribution is likely to be
minimal. In situ antibody labelling showed strong nuclear
expression of active Notch1 that was detected throughout the
epidermis in the inﬂammatory phase. Moreover, at 7 dpw, when
Notch1 levels decreased in wounds as detected by protein
blotting, macrophages are still persistent within the dermis.
It is well established that Notch1 has a cell-autonomous role
in lineage speciﬁcation of cells within both adaptive and innate
immune systems51. Here, we demonstrate that Notch activity in
non-immune cells initiates an event cascade controlling
inﬂammation and immune regulation in the skin. Neutrophil
recruitment, however, was unaffected by changes in Notch1
activity (Fig. 2a). Neutrophil recruitment is mediated by the
release of danger signals or damage-associated molecular
patterns, normally cytoplasmic DNA, from disrupted cells and
tissues. It has been shown previously that neutrophils are
recruited to sites of sterile skin injury in a leukotriene
LTB4 dependent process and occurs in very short time scales,
thus we believe it is completely independent of the Notch-
mediated recruitment of ILC3s and other innate immune
cells52,53.
Recruitment of NKp46low/ ILC3s into wounded dermis from
the circulating blood was demonstrated by localization of dermal
ILC3s after transfer of Rag2 / splenocytes into RORg-deﬁcient
mice. ILC3s can be detected in human blood and in psoriasis
lesions; the number of ILC3s in blood increased correspondingly
with the inﬂux of dermal ILC3s23. Recruitment of ILCs into
mucosal epithelia is a CCL20/CCR6 dependent process54, and
we hypothesized that Notch1-mediated, wound-induced ILC3
recruitment would employ similar mechanisms. However, results
from genetic deletion of the CCL20/CCR6 or CXCL13/CXCR5
signalling in CCR6 / and CXCL13 / deﬁcient mice suggest
redundancy in cell recruitment mechanisms, implicating a
potential role for other chemotactic factors including CXCL16,
sphingosphine-1-phosphate, prosteoglandins, retinoic acid and
other chemokines all known to be expressed in the skin55.
CXCL12 may also function as a chemotactic factor. Although we
detected no change in CXCL12 gene transcription within 24 h of
injury (Fig. 5c), activated platelets are a potent source of CXCL12
(ref. 56). Thus, it cannot be ruled out that platelet-derived
CXCL12 protein may contribute to ILC3 recruitment into skin
wounds. Modulating TNFa levels had a direct consequence on
the number of ILC3s at wound sites and the rate of wound
healing. Moreover, Notch is a powerful inducer of TNFa and
blocking TNFa activity downstream of activated Notch reduced
the number of dermal ILC3s9.
RORgþ ILC3s help facilitate skin repair through promoting
epidermal re-epithelialization and monocyte/macrophage
recruitment into the dermis in addition to the role of RORgþ
LTi cells in lymphoid tissue formation. Using a combination of
Thy1.2 depleted Rag2 / mice and cell transfers we have
shown there is no connection between lymphoid tissue
formation and ILC3 function in skin wound repair. What
remains uncertain is whether ILCs have discrete roles in both
these processes, or whether detected changes in epithelial
proliferation are a direct consequence of delayed early macro-
phage inﬂux into wounds. ILC3s secrete CCL3, an important
monocyte/macrophage chemokine attractant57, early (2 dpw)
but not later (5 dpw) in the wound repair programme. RORg /
 mice had reduced levels of CCL3 mRNA at 2 dpw compared
to wildtype controls and T lymphocyte deﬁcient Rag2 / mice.
These data suggest simplistically that, in the absence of ILC3s,
reduced CCL3 production is the cause of delayed macrophage
entry. However, in reality macrophage recruitment into injured
tissues is much more complex. Macrophages themselves can
produce CCL3 and other chemokines, including CXCL2 (also
known as MIP2) and CCL2, have key recruitment functions58–
60. Further, more recent work has identiﬁed that monocytes with
distinct phenotypic characteristics are recruited into wound
tissues at different times, suggesting an additional speciﬁcity of
macrophage recruitment signalling that is yet to be fully
understood61.
In conclusion, we propose that Notch1 acts a damage ‘‘sensor’’
in epithelial tissues, transmitting a ‘‘stress/injury signal’’ and
instigating tissue repair through recruitment of ILC3s and
macrophages. Given the importance of ILC3s and Notch
signalling in maintenance and organization of the intestinal
epithelium, we propose that it is likely a Notch-mediated ‘‘signal’’
is conserved amongst epithelial tissues required to undergo
periodic repair.
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Figure 8 | Notch1 orchestrates wound healing through control of type
3 innate lymphoid cells (ILC3s). Skin wounding activates Notch pathway
(orange cells) in the basal and suprabasal epidermis. Epidermal Notch1
regulates chemokine production in epidermal and dermal cells; injury-
induced Notch1 activity upregulates TNFa, which can induce CCL20 in
epidermal and dermal cells (grey cells). TNFa downstream of Notch1
regulates ILC3 localization within the dermis surrounding the wound and
ILC3s are key sources of IL17F and early CCL3 production in the wound-
healing cascade. ILC3s subsequently inﬂuence epidermal proliferation and
macrophage (Mf) recruitment, two key events in the skin wound-healing
programme.
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Methods
Animal models. K14NICDER (C57BL/6CBA background) and RORg / ,
Rag2 / , CCR6 / and CXCL13 / mice in C57BL/6 background have been
described previously9,62–64. All experimental procedures were performed with
ethical permission by Durham and University of York under UK government
Home Ofﬁce licences to CA and MC (60/3941 and 60/4178). Experiments followed
the national and institutional guidelines for the care and use of animals on the basis
of the Animal (Scientiﬁc Procedures) Act 1986 and where possible ARRIVE
guidelines. The effect of RORg deletion on wound healing was previously
uninvestigated, thus pre-speciﬁed effects prior to experimentation could not be
determined and power calculations were not employed. Mice were housed in
pathogen-free facilities and had access to food and water ad libitum. In
K14NICDER mice, ER-inducible transgenes were activated by topical application
of 2mg of 4OHT (H6278, Sigma) dissolved in acetone.
For wounding experiments, mice were anesthetized using 2% inhaled isoﬂurane
and then injected subcutaneously with the analgesic, Vetergesic (0.05mg kg 1,
Alstoe Animal Health). The back skin was shaved and sterilized with Videne
surgical scrub (Ecolab) then rinsed with sterile water. Then two full-thickness,
4mm diameter back skin wounds with a minimum distance of 1 cm apart were
made using a punch biopsy (Stiefel). Some wounds were topically treated daily with
recombinant TNFa (8mg kg 1, product code: PNRMTNFAI, Thermo Scientiﬁc
Pierce), TNFa blocking antibody (10mg kg 1, Adalimumab, Humira, Abbott
Laboratories) or PBS until humanely sacriﬁced 2 or 5 dpw49. Some mice were
injected intraperitoneally with anti-NRR1 (5mg kg 1, Genentech), anti-NRR2
(5mg kg 1, Genentech) or control (anti-ragweed, Genentech) IgG (5mg kg 1) for
7 days before wounding and then every 2–3 dpw for the duration of the
experiment30. Some RORg / mice were injected intravenously with 1 106
splenocytes derived from Rag2 / mice 24 h before wounding. Some Rag2 /
mice were injected intraperitoneally with 200 ng anti-Thy1.2 antibody (BioXcell,
30H12) every other day for 2 weeks before wounding24,44. Mice were kept up to 8
dpw and wounds were measured with a calliper or quantiﬁed using a 3D camera
(Quantiﬁcare).
Wounds were photographed using a 3D camera (Quantiﬁcare) during the
healing response. Each wound was photographed three times at each time point,
with each image analyzed three times to check for measurement consistency. Each
image was assigned a random code and blind analysis was carried out using
Dermapix software (Quantiﬁcare). Wound perimeters and diameters were
recorded along with observations of the image (for example, excessive glare from
the camera ﬂash), and outliers excluded as appropriate when images could not be
processed due to camera angle, excessive glare or obscured wound region.
In every experiment mice were age and sex matched, with wildtype littermate
controls used when possible, and within each experiment 3 or more mice per
genotype/experimental group were included. Experiments were repeated two to
four times to conﬁrm results. The majority of mice reported were females between
6 and 9weeks of age. Occasionally, male mice or mice between 9 and 18weeks were
included in an experiment, however RNA and protein analysis was performed on
age and sex-matched tissues and analysis was performed among experimental
replicates where appropriate. Unexpectedly, rare RORg / mice developed
leukaemia while undergoing experimental procedures and these mice were
excluded from analysis. In addition, some larger wounds were made by 6mm
punch biopsy (Supplementary Fig. 7f) for wound closure study.
Antibody labelling. Tissue was collected and processed as previously described9.
8 mm-thick frozen or parafﬁn sections were ﬁxed in 4 or 0.4% paraformaldehyde,
blocked in 10% goat or donkey serum, 0.25% ﬁsh skin gelatin and 0.2% bovine
serum albumin, and then stained with antibodies diluted in blocking solution.
Tissue sections were stained with ﬂuorescent secondary antibodies (1:1,000,
Invitrogen) and DAPI counterstained before imaging using a Leica Tandem SP5,
Zeiss 710 or Zeiss 880 confocal microscope. For intracellular staining, frozen
sections were ﬁxed with 4% PFA, blocked as described above and incubated with
ﬂuorescence conjugated conjugated RORg antibody diluted in permeabilization
buffer (eBiosciences, cat. 00-8333) for 2 h. Brightness of images was adjusted using
Adobe Photoshop CS3 software. See below for list of antibodies, suppliers and
working dilutions.
Flow cytometry. An 8 8mm piece of mouse back skin including wounded area
was removed from and the ventral surface was scraped gently with a scalpel to
remove subcutaneous fat and muscle. Tissue was chopped into pieces and
incubated with 0.35mgml–1 Liberase TL (Roche, Cat: 5401020001), 3mgml 1
Collagenase D (Roche, Cat: 11088866001) and 0.1mgml 1 DNase I (Roche,
Cat: 10104159001) in RPMI Media 1640 (Life Technologies, Cat: 31870-025) at
37 C for 2 h. After incubation, the digested tissue was put through a 70 mm strainer
to isolate single cells. Cells were pelleted and re-suspended in 0.5% BSA/2mM
EDTA in PBS, then were blocked with anti-mouse CD16/32 (Biolegend,
Cat:101320) and rat IgG (Sigma, Cat: I8015-10mg) for 20min before antibody
staining for ﬂow cytometry. For intracellular staining of RORgt, cells were ﬁrst
stained for surface markers as described above, then ﬁxed overnight in Foxp3
Fixation/Permeabilization (eBiosciences Cat: 88-8824). After incubation, a RORgt
antibody (BD, Q31-378, 1:100) was added to the cells for 1 h before analyzing cells.
For cytokine and chemokine staining, single cell suspensions were incubated
with 50 ngml 1 PMA (Phorbol 12-myristate 13-acetate; Sigma, P1585) and
5 ngml 1 ionomycin (Sigma, 10634) in the presence of 10 mgml 1 brefeldin
A (Sigma, B5936) for 3 h before surface staining as described above. Cells were
ﬁxed in Foxp3 Fixation/Permeablization buffer (eBioscience, 88-8824) overnight,
then antibodies to IL22, IL17A, IL17F and/or MIP1a (CCL3) and isotype controls
were added to the cells for 1 h before analyzing cells. Cells were analyzed using a
BD LSR Fortessa. See below for list of antibodies, suppliers and working dilutions.
Antibodies for mouse ﬂow cytometry and immunohistochemistry. Flow
cytometry. CD45 (Biolegend, 30-F11, 1:100), Lineage cocktail (eBioscience, inclu-
ding17A2, RA3-6B2, M1/70, TER-119, RB6-8C5, 1:100), CD3 (eBioscience, 17A2,
1:100), CD3e (BD Biosciences, 145-2C11, 1:100), CD4 (eBioscience,RM4-5, 1:100),
CD8 (Biolegend, 53-6.7, 1:100), F4/80 (eBioscience, BM8,1:400), CD11b (Biole-
gend, M1/70, 1:1000), Gr-1 (eBiosiences, RB6-8C5, 1:100), NK1.1 (Biolegend,
PK136), NKp46 (Biolegend, 29A1.4, 1:100), CD117 (eBioscience, 2B8, 1:100),
CD127 (eBioscience, A7R34, 1:100), CXCR5 (Biolegend, L138D7, 1:100), CXCR4
(Biolegend, L276F12, 1:100), CCR6 (Biolegend, 29-2L17, 1:100), ST2 (eBioscience,
RMST2-2, 1:100), CD25 (Biolegend, PC61.5, 1:100), RORgt (BD, Q31-378, 1:100),
IL22 (eBioscience, 1H8PWSR, 1:100), IL17A (Biolegend, TC11-18H10.1, 1:100),
IL17F (Biolegend, 9D3.1C8, 1:100) and MIP1a (CCL3) (eBioscience, DNT3CC,
1:100).
Immunohistochemistry. F4/80 (eBioscience, BM8,1:400), CD3 (eBioscience,
17A2, 1:100), CD4 (eBioscience, RM4-5, 1:100), CD117 (eBioscience, 2B8, 1:100),
CD127 (eBioscience, A7R34, 1:100), RORgt (eBioscience, AFKJS-9, 1:100 or BD,
Q31-378, 1:100), activated Notch1 (Abcam, ab8925, 1:200), Ki67 (Abcam or
Novocastra, NCL-Ki67p, 1:400), Gr-1 (eBiosiences, clone BM8, 1:100), a6 integrin
(Abcam, 105669, 1:400). Jagged 1 (Santa Cruz Biotechnology, SC-6011, 1:100) and
K10 (Biolegend, 905401, 1:1000).
Western blotting. A small region of the skin containing the wound and the region
just adjacent to the wound (approximately 0.5–1 cm2) was excised from the back
skin. The tissue was homogenized using a polytron tissue homogenizer in RIPA
lysis buffer (150mM NaCl, 50mM Tris–HCl (pH 7.5), 1% Nonidet P-40, 0.25%
sodium deoxycholate with protease inhibitors). Lysate supernatants were run on a
6 or 10% polyacrylamide gel, transferred to PVDF membrane, blocked with 3%
cold water ﬁsh skin gelatin (Sigma)/0.2% Tween-20/PBS and hybridized with
antibodies to activated Notch1 (ab8925, 1:400, Abcam), activated Notch2 (ab8926,
1:400, Abcam) or beta-actin (A5441, 1:3000, Sigma). Blots were rinsed in 0.2%
Tween-20/PBS, incubated with HRP-conjugated anti-rabbit or anti-mouse
secondary antibody (Sigma) and visualized with ECL Western Blotting Substrate
(Pierce). Following ﬁlm detection of blots, band intensity was quantiﬁed using
ImageJ and the mean band intensity value was calculated against the loading
control (Fig. 1 and Supplementary Fig. 5). Images have been cropped for
presentation (Supplementary Fig. 5). Full-size images of western blots are presented
in Supplementary Fig. 9.
RNA extraction and quantitative polymerase chain reaction. Wounded back
skin tissues were collected as above and RNA was extracted from freshly-isolated
tissues, from tissues snap frozen in liquid nitrogen at the time of collection or from
tissues immersed in RNAlater (Invitrogen, R0901) for 24 h before freezing. Tissues
were homogenized using polytron tissue homogenizer then RNA was isolated using
RNeasy Mini Kit (Qiagen, 74104) following manufacturer’s instructions including
the optional, on-column DNAse I digestion step using RNase-free DNase set
(Qiagen, 79254). An additional Proteinase K digestion step was performed
in the protocol: homogenized lysates were incubated with 0.2mgml 1 Proteinase
K (Sigma, P2308) in RLT buffer (Qiagen) at 55 C for 10min. Harvested RNAs
were quantiﬁed using a NanoDrop microspectrophotometer and cDNA were
prepared using High Capacity cDNA Transcription kit (Life Technologies,
Cat: 4368814).
qPCR was performed using a StepOnePlus Real-Time PCR System instrument
(Life Technologies, Cat. 4376600), with a standard quantitation-comparative
Ct procedure as set by the manufacturer. Triplicate reactions (25 ml) of each
experimental sample were prepared using CYBR master mix (Life Technologies,
Cat: 4367659) and unlabelled primers for CXCL12, CXCL13, CCL3 and HPRT
(control). Reactions were subjected to an initial 10-minute denaturation step at
95 C, followed by 40 cycles of 95 C for 15 s and 60 C for 60 s. CCL20 and TNFa
mRNA levels were examined using FAM probes and TaqMan Fast Master Mix
(Life Technologies, 4352042) with a fast quantitation-comparative Ct procedure.
Reference gene GAPDH was used as internal control. Reactions (20 ml) were
subjected to an initial 20-s denaturation step at 95 C, followed by 40 cycles of
95 C for 3 s, 60 C for 30 s.
An alternative qPCR method to quantify CCL20 (Supplementary Fig. 6f) was
performed using a Rotor-Gene Q instrument (Qiagen), with a two-step rapid-
cycling procedure as described by the manufacturer (Rotor-Gene Probe
Handbook, Qiagen). Triplicate reactions (20 ml) of each experimental sample
were analysed using a FAM probe for CCL20 and TaqMan Fast Universal PCR
master mix (ABI). Reactions were subjected to an initial 3-minute denaturation
step at 95 C, followed by 45 cycles of 95 C for 3 s and 60 C for 10 s. Data were
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analysed using the Comparative Quantitation algorithm in the Rotor-Gene
software, with calibrator samples for each run being compared in a common
experiment. PCR reactions: 95 C for 3 mins, followed by 45 cycles of 95 C for
20s. A FAM probe for reference gene GAPDH was used to quantify genes of
interest.
Unlabelled primers and FAM probes for qPCR. All primers were used at a ﬁnal
concentration of 400 nM.
CXCL12: Forward 50-CAGAGCCAACGTCAAGCA-30 , Reverse 50-AGGTA
CTCTTGGATCCAC-30
CXCL13: Forward 50-CATAGATCGGATTCAAGTTACGCC-30, Reverse
50-TCTTGGTCCAGATCACAACTTCA-30
CCL3: Forward 50-GTTCTTCTCTGTACCATGAC-30; Reverse 50-CTCTTAG
TCAGGAAAATGAC-30
Control HPRT: Forward 50-AGGAGTCCTGTTGATGTTGCCAG-30 , Reverse
50-GGGACGCAGCAACTGACATTTCT-30
Jagged1 Forward: 50-AGAAGTCAGAGTTCAGAGGCGTCC-30 , Reverse:
50-AGTAGAAGGCTGTCACCAAGCAAC-30
Jagged2 Forward: 50-CAATGACACCACTCCAGATGAG-30 , Reverse: 50-GGC
CAAAGAAGTCGTTGCG-30
FAM probes. IL22: Mm01226722_g1, Life Technologies
CCL20: Mm01268754_m1, Life Technologies
TNFa: Mm00443258_m1, Life Technologies
GAPDH: Mm99999915_g1, Life Technologies
Systems biology analysis of gene expression data sets. To determine key
signalling pathways involved in Notch-mediated wound healing we used unbiased
analysis of gene arrays from RORgþ innate lymphoid cells (NIH GEO:
GSE29777)31 and from uninjured, K14NICDER transgenic mouse back skin
epidermis and dermis (NIH GEO: GSE23782)9. The MAS5-processed datasets of
differentially expressed genes were imported into Ingenuity Pathway Analysis
software (Ingenuity Systems, www.ingenuity.com) for analysis. All secreted,
skin-derived factors that could interact with a receptor on ILC3s were determined.
The highly upregulated genes in the epidermis and the dermis were ﬁltered by the
‘extracellular matrix’ gene ontology term. Ingenuity Pathway Analysis was used to
build direct connections from the upregulated genes to their possible target
receptors. The genes displayed in Fig. 5 were further selected to show the most
probable/relevant/interesting interactions between secreted factors and their target
receptors.
Human cutaneous wound biopsies. Full-thickness punch biopsies (diameter
5mm) were taken from the medial aspect of the upper arm of ﬁve healthy ethically
consented Caucasian volunteers (male and female; aged 18–28; REC ethics refer-
ence: 09/H1012/3). These were left to heal by secondary intention. After 3 and
7 days the initial wound sites were biopsied again (diameter 7mm) so that the
entire wound site was collected with some adjacent uninjured wound margin tissue.
Samples were snap frozen in liquid nitrogen immediately following biopsy,
embedded in OCT (CellPath, UK) and set on dry ice. Samples were stored
at –80 C until cryosectioning for further analysis.
Cryosections of the tissue (6 mm) were allowed to reach room temperature
and ﬁxed in ice cold acetone at 4 C for immunohistochemistry (IHC) or in
formalin for H&E staining. Slides were then allowed to air dry at room
temperature and washed in TBS before commencement of the
immunohistochemical or histochemical protocol. For H&E, slides were
ﬁrst submerged in modiﬁed Harris Haematoxylin (Thermo Scientiﬁc, UK)
for 4min, washed in tap water and counterstained in Eosin (Thermo
Scientiﬁc, UK) for 1min. Stained slides were dehydrated through an ethanol
gradient, cleared with xylene and mounted.
For IHC, a sequential triple stain was performed. Slides were blocked in
TBS with 10% (v/v) normal donkey serum and normal human serum. After
three washes with TBS, a ﬁrst incubation with mouse monoclonal Anti-RORC
(1:50, MABF81, Millipore) and rabbit monoclonal anti-CD3 (1:100, AC-004 A,
Epitomics) was performed for 1 h at room temperature. Sections were washed with
TBS-tween-20 (0.01% (v/v) then incubated with secondary antibodies (Alexa-488
Donkey anti-mouse, 1:250; Alexa-555 Donkey anti-rabbit, 1:150) for 1 h at room
temperature. After washing again, sections were blocked with TBS containing 10%
(v/v) normal mouse serum. A second incubation with the third primary antibody,
mouse monoclonal anti-CD127 (IL-7Ra) (1:100, A18684, Life Technologies), was
then performed for 1 h at room temperature, followed by washing with TBS-
Tween-20. Sections were then incubated with alexa-647 donkey anti-mouse (1:250)
for 1 h at room temperature, washed and counterstained with DAPI (1:500) for
15min at room temperature. Slides were given a ﬁnal wash, dried and mounted
using Vector Shield. Slides were scanned on a Pannoramic 250 Flash II, 3DHistech
Ltd. and analysed through the Pannoramic Viewer platform (v.1.15.2 created by
3DHistech Ltd).
Primary dermal cells. Primary mouse ﬁbroblasts were isolated using a method on
the basis of Jahoda et al.65. In brief, after sacriﬁcing the mouse, the back skin hair
was clipped and then the skin tissue and washed in DMEM (Invitrogen) with
double strength antibiotics (2 Pen/Strep—Penicillin 100Uml 1 Streptomycin
100 mgml 1). The fat and non-dermal tissue was gently scraped from the tissue
before cutting into pieces of B10mm2. Each piece of tissue was cut repeatedly
using curved blade scissors until it became slurry and the tissue was spread onto
the bottom of a 6-well plate. The tissue was then covered with DMEMþ 10% foetal
calf serum and 1 Pen/Strep (Fisher) and placed in a 37 C incubator at 5% CO2.
After 12 days cells were passaged.
P1 mouse ﬁbroblasts 90% conﬂuent were treated with either 1:1,000 TNFa
(20 ngml 1, product code: PNRMTNFAI, Thermo Scientiﬁc Pierce), 1:1,000
TNFa blocking antibody (50 mgml 1, Adalimumab, Humira, Abbott Laboratories)
or both diluted in DMEMþ 10% FCS (PAA Laboratories) and 1 Pen/Strep.
Some cells were left untreated. Cells were incubated for an additional 24 h then
lysed and RNA collected using an RNAeasy Mini Kit (Qiagen) following the
manufacturer’s protocol.
Statistics. For western blotting and mRNA quantiﬁcation, samples were
normalized where the average of the uninjured skin control, unless otherwise
stated, was designated as 1 or 100%. The number of independent samples is stated
in the ﬁgure legends. Statistical analysis was performed using SPSS (IBM) and
Prism GraphPad software. Data variances were calculated and normal distribution
of the data was determined by Kolmogorov–Smirnov tests. Normally-distributed
data were analysed by two-way ANOVA with statistical signiﬁcance between zones
at calculated by Bonferroni’s multiple comparison test or Student’s t-test.
Non-normally-distributed data was analysed using a Mann–Whitney test. %
wound openness (Fig. 7b and Supplementary Fig. 7) was calculated using
a linear mixed effects model. Speciﬁc P-values are included on ﬁgures or in ﬁgure
legends.
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